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ABSTRACT. We report the case of an elderly im-
munocompetent patient with Aeromonas hydrophila
bacteremia without evidence of portal of entry. Despite
several risk factors for a poor outcome, such as im-
paired renal function, two positive blood cultures,
and community-acquired infections, the patient sur-
vived. Antimicrobial susceptibility was normal. Un-
known polycystic liver disease was discovered and
misdiagnosed as a hepatic abscess at the time of the
bacteremia which was confirmed by repeated CT scans.
Because of the absence of other risk factors for
Aeromonas bacteremia, hepatic polycystic disease may
take part in the onset of Aeromonas sp bacteremia as
well as immunosenescence.
(Aging Clin Exp Res 2006; 18: 344-346)
©2006, Editrice Kurtis
INTRODUCTION 
Aeromonas species, previously classified as Vibri-
onaceae, are Aeromonadaceae ubiquitous gram-negative
bacilli, widely distributed in aquatic ecosystems (freshwater
and marine environments) and isolated with increased
frequency in summer. In humans, Aeromonas causes a
wide variety of infections, including wound infections,
bacteremia and diarrhoea, in immunocompromised pa-
tients and rarely in immunocompetent individuals (1). 
We report a case of bacteremia caused by Aeromonas
hydrophila in an immunocompetent patient without ev-
ident exposure to an aquatic source in a geriatric hospital
in Geneva in 2001.
CASE REPORT 
An 87-year-old man was admitted to the Geriatric
Hospital of Geneva in July 2001 with fever and chills
which had lasted two days before admittance, and fatigue
during the previous month. His medical history included
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Parkinson's disease since 1995, a sylvian stroke with re-
gressive aphasia in 1999, hypertension, and chronic re-
nal insufficiency.
At admission, physical examination revealed a relatively
healthy man, with a normal body temperature and no oth-
er significant symptoms.
Laboratory tests showed pancytopenia (Hb 12.5 g/dl,
WBC count 3.3x10p9/l, platelet count 119000/mm3).
Electrolyte levels were within normal range, serum crea-
tinine concentration was 145 umol/l, and  Protein C re-
active 169 mg/l.
Two blood cultures revealed Aeromonas hydrophila.
The isolated germ was susceptible to second- and third-
generation cephalosporin and quinolones, and resistent to
amoxicillin, co-amoxyclav and first-generation
cephalosporin. Urine and stool cultures were negative.
The chest film was normal. An abdominal scan showed
multiple hypodense lesions, the largest being 18 mm in
cross section. At this point, differential diagnosis indicated
metastatic septic lesions or hepatic cysts. In accordance
with susceptibility patterns, the patient was treated with
ciprofloxacin 500 mg 2x/day for one month. Clinical evo-
lution was favorable over the first five days. Pancytopenia
disappeared on the 6th day. PCR was less than 3 mg/l af-
ter 3 weeks. As there was no change in the hepatic le-
sions after 1 and 3 months, our diagnosis was polycystic
liver disease. Exposure to Aeromonas may have been by
drinking freshwater  near his home but no bacteriological
analysis was performed.
DISCUSSION 
Aeromonas species are considered as predominantly
pathogenic to poikilotherms (1). However, they have
emerged as an important human pathogen and the cause
of a wide range of diseases. Transmission may occur
through water and food (2, 3).
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Aeromonas are responsible for the following infec-
tions: mild to severe wound infections, almost always fol-
lowing traumatic aquatic exposure or after immersion in
water immediately after burns (3, 4); and acute or
chronic diarrhoea in the community, with increased
isolation in patients with traveller's diarrhoea, but also in
long-term care settings (5, 6). Aeromonas sp causes bac-
teremia mostly in patients with malignancy or other
immunocompromising conditions such as serious liver
disease (mostly hepatic cirrhosis), or traumatic injuries (7). 
The largest trial on Aeromonas infections was carried
out in Taiwan from 1989 to 1998, with 104 episodes
of monomicrobial Aeromonas bacteremia (7). Interest-
ingly, there was a predominance of males (80%), and
age ranged from 14 to 96, with a mean of 53.6 years.
The two common underlying diseases were hepatic cir-
rhosis (54%) and malignancies (21%). Most cases were
community-acquired (74%). Impaired renal function at
presentation, more than one set of positive blood cul-
tures, community-acquired infections, hepatic cirrho-
sis as underlying illness, and secondary bacteremia,
were independently associated with a fatal outcome.
Gender, age and bacterial species did not affect the
clinical outcome. An additional infection focus was
found in only 43% of patients. Despite the age of the
patient reported here, who presented with several wors-
ened prognostic factors (impaired renal function, two
positive blood cultures, community-acquired infections),
his condition improved rapidly and the outcome was fa-
vorable.
Janda and Abbott proposed four major categories of
persons susceptible to Aeromonas septicemia (8). Two are
immunocompromised adults (due to malignant diseases or
hepatic cirrhosis) and infants under 2 years of age with
multiple underlying medical complications, both of which
develop sepsis by bacterial translocation from the intestine
into the bloodstream after colonization of the gastroin-
testinal tract. A third group is observed to develop sepsis
as a result of wound infections. A fourth group, an ex-
tremely small collection of cases, is composed of pa-
tients with neither underlying defects nor exposure to
sources of freshwater.
Our case was of interest because of the presence of
polycystic liver disease, never reported before, as a pos-
sible favoring condition and the absence of exposure to
a freshwater source. Infection of cysts occurs essentially
by enterobacteria, and there are no reports of
Aeromonas as causal agent (9). In our case however, it
is not clear whether there was a cyst infection. Abdom-
inal scanning revealed no argument for infection, there
was no change after antibiotic treatment, and percuta-
neous aspiration of cysts to confirm infection was not car-
ried out because of the favorable evolution. In addition,
the decreased immune function related to aging may have
contributed to the onset of bacteremia. However, there
are not many reports on Aeromonas infections in the el-
derly. One might argue that very old individuals are
probably rarely exposed to the bacterium, but also that
even scarce exposure is sufficient to induce infection. This
may also have been the case for our patient, because of
exposure to freshwater. According to the patient, “drink-
ing freshwater near his home” was a possibility, but
when was not ascertained. In addition, this hypothesis
could not be confirmed by serial bacteriological analysis
of the freshwater in question. It should be mentioned that
this is the first Aeromonas bacteremia report in Switzer-
land. In the University Hospital of Geneva there have on-
ly been nine episodes of Aeromonas bacteraemia in
the last ten years (5 Aeromonas hydrophila, 3 caviae,
1 sobria) (unpublished data, Dr Rohner P.). The incidence
of disease caused by Aeromonas in Switzerland is not
well known. In the only trial conducted among adults with
diarrhoea in Switzerland, stool specimens from through-
out the country showed 8% Aeromonas sp, but there is
no information regarding the locations of other infections
and bacteremia (10). 
Aeromonas sp. are naturally resistent to penicillin,
ampicillin and ticarcillin, but susceptible to second- and
third-generation cephalosporin, and other antibiotics
such as quinolones, aminoglycosides, cotimoxazole, chlo-
ramphenicol and tetracyclines. There is a clear difference
in antibiotic susceptibility among species, underlining
the need for identification and susceptibility testing of all
isolates (1). In our case, the isolated Aeromonas hy-
drophila was susceptible to second- and third-generation
cephalosporin and quinolones as known for Aeromonas
hydrophila.
Cases of Aeromonas bacteremia are still rare in pre-
sumably immunocompetent individuals. However, such in-
fections may become more frequent in healthy elderly as
far as the elderly population increases and may be more
frequently exposed to Aeromonas sp bacteria. 
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